• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Respirology . Epidemiology, clinical spectrum, viral kinetics and impact of COVID-19 in the Asia-Pacific region

tetano

Editor, Senior Moderator
Respirology


. 2021 Mar 9.
doi: 10.1111/resp.14026. Online ahead of print.
Epidemiology, clinical spectrum, viral kinetics and impact of COVID-19 in the Asia-Pacific region


Kin On Kwok[SUP] 1 2 3 [/SUP], Ying Huang[SUP] 1 [/SUP], Margaret Ting Fong Tsoi[SUP] 1 [/SUP], Arthur Tang[SUP] 4 [/SUP], Samuel Yeung Shan Wong[SUP] 1 [/SUP], Wan In Wei[SUP] 1 [/SUP], David Shu Cheong Hui[SUP] 2 5 [/SUP]



Affiliations

Abstract

COVID-19 has hit the world by surprise, causing substantial mortality and morbidity since 2020. This narrative review aims to provide an overview of the epidemiology, induced impact, viral kinetics and clinical spectrum of COVID-19 in the Asia-Pacific Region, focusing on regions previously exposed to outbreaks of coronavirus. COVID-19 progressed differently by regions, with some (such as China and Taiwan) featured by one to two epidemic waves and some (such as Hong Kong and South Korea) featured by multiple waves. There has been no consensus on the estimates of important epidemiological time intervals or proportions, such that using them for making inferences should be done with caution. Viral loads of patients with COVID-19 peak in the first week of illness around days 2 to 4 and hence there is very high transmission potential causing community outbreaks. Various strategies such as government-guided and suppress-and-lift strategies, trigger-based/suppression approaches and alert systems have been employed to guide the adoption and easing of control measures. Asymptomatic and pre-symptomatic transmission is a hallmark of COVID-19. Identification and isolation of symptomatic patients alone is not effective in controlling the ongoing outbreaks. However, early, prompt and coordinated enactment predisposed regions to successful disease containment. Mass COVID-19 vaccinations are likely to be the light at the end of the tunnel. There is a need to review what we have learnt in this pandemic and examine how to transfer and improve existing knowledge for ongoing and future epidemics.

Keywords: COVID-19; clinical spectrum; epidemiology; impact; viral kinetics.
 
Back
Top Bottom